GlassScriptPhysician profile
Karie B Robinson
NPI 1023075033
$1,896.30
in general payments reported to CMS, 2019-2025
10 companies · $166 in 2025
The $166 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $646 · 2023: $861 · 2024: $224 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $650 · Consulting Fee: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $650.00 |
| Consulting Fee | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mirum Pharmaceuticals, INC. | $1,431.30 | 2022-2025 | Livmarli |
| Ironwood Pharmaceuticals, INC | $118.68 | 2023-2024 | Linzess |
| Qol Medical, LLC | $102.33 | 2022-2025 | Sucraid, Sucraid |
| Ipsen Biopharmaceuticals, INC | $81.42 | 2024-2025 | Bylvay |
| Takeda Pharmaceuticals U.S.A., INC. | $42.54 | 2024-2025 | Eohilia |
| Alcresta Therapeutics, INC. | $33.74 | 2023 | Relizorb |
| Janssen Biotech, INC. | $27.35 | 2023 | Stelara |
| Eton Pharmaceuticals, INC. | $23.17 | 2025 | Galzin, Betaine Anhydrous, Nitisinone |
| Fresenius Kabi USA, LLC | $18.96 | 2023 | Idacio |
| Abbvie INC. | $16.81 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karie Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.